The angiotensin-converting enzyme DD gene is associated with poor prognosis in Finnish sarcoidosis patients

Angiotensin-converting enzyme (ACE) genotypes may reflect prognosis in sarcoidosis. They were determined in 59 Finnish sarcoidosis patients and 70 healthy control subjects. The prognosis of the sarcoidosis patients was determined after follow-up for 1, 2, 3, 5 and >5 yrs and classified as good (normal chest radiograph and lung function, no signs of extrapulmonary disease activity within 2 yrs from diagnosis), intermediate (neither good nor poor) or poor (persisting unstable pulmonary infiltrates, vital capacity and diffusing capacity of the lung for carbon monoxide <50% predicted and/or extrapulmonary disease activity after >5 yrs follow-up). The DD, ID and II genotypes were found in 31 and 27%, in 54 and 49%, and in 15 and 24% of patients and control subjects respectively. The odds ratio (DD+ID to II) was 1.45 (95% confidence interval 0.60-3.49). The D alelle was found more often in patients (58%) and in control subjects (51%) than the I allele but the difference was not statistically significant. Statistically significantly more patients with the DD genotype had a poor prognosis compared with patients with II homozygotes and ID heterozygotes. Among 11 patients with Lofgren's syndrome (bilateral hilar lymphadenopathy and erythema nodosum), four had the DD genotype. Three of these patients had a prognosis despite presenting a clinical picture usually associated with a good prognosis. The angiotensin-converting enzyme genotype may be a prognostic marker in sarcoidosis and larger studies are warranted to define its clinical utility.

This article has been cited by other articles:

				B. J. Plant, S. Ghani, M. J. O'Mahony, L. Morgan, C. M. O'Connor, K. Morgan, J. A. Baugh, and S. C. Donnelly Sarcoidosis and MIF gene polymorphism: a case-control study in an Irish population Eur. Respir. J., February 1, 2007; 29(2): 325 - 329. [Abstract] [Full Text] [PDF]

				B.A. Rybicki, M.J. Maliarik, L.M. Poisson, and M.C. Iannuzzi Sarcoidosis and granuloma genes: a family-based study in African-Americans Eur. Respir. J., August 1, 2004; 24(2): 251 - 257. [Abstract] [Full Text] [PDF]

				S. Rothkrantz-Kos, M. P. van Dieijen-Visser, P. G.H. Mulder, and M. Drent Potential Usefulness of Inflammatory Markers to Monitor Respiratory Functional Impairment in Sarcoidosis Clin. Chem., September 1, 2003; 49(9): 1510 - 1517. [Abstract] [Full Text] [PDF]

				R. P. Baughman and E. E. Lower The Variability of Sarcoidosis: Can We Predict It? Chest, May 1, 2003; 123(5): 1329 - 1332. [Full Text] [PDF]

				D. R. Moller and E. S. Chen Genetic Basis of Remitting Sarcoidosis: Triumph of the Trimolecular Complex? Am. J. Respir. Cell Mol. Biol., October 1, 2002; 27(4): 391 - 395. [Full Text] [PDF]

				R. M. du Bois The Genetic Predisposition to Interstitial Lung Disease : Functional Relevance Chest, March 1, 2002; 121(2007): 14S - 20S. [Abstract] [Full Text] [PDF]

				D. S. McGRATH, P. J. FOLEY, M. PETREK, L. IZAKOVICOVA-HOLLA, V. DOLEK, S. VEERARAGHAVAN, P. A. LYMPANY, P. PANTELIDIS, A. VASKU, A. U. WELLS, et al. ACE Gene I/D Polymorphism and Sarcoidosis Pulmonary Disease Severity Am. J. Respir. Crit. Care Med., July 15, 2001; 164(2): 197 - 201. [Abstract] [Full Text] [PDF]

				U. Costabel Sarcoidosis: clinical update Eur. Respir. J., July 1, 2001; 18(32_suppl): 56S - 68s. [Abstract] [Full Text] [PDF]

				J. Grunewald and A. Eklund Human leukocyte antigen genes may outweigh racial background when generating a specific immune response in sarcoidosis Eur. Respir. J., May 1, 2001; 17(5): 1046 - 1048. [Abstract] [Full Text] [PDF]

				E. Yamaguchi, A. Itoh, N. Hizawa, and Y. Kawakami The Gene Polymorphism of Tumor Necrosis Factor-{beta}, But Not That of Tumor Necrosis Factor-{{alpha}}, Is Associated With the Prognosis of Sarcoidosis Chest, March 1, 2001; 119(3): 753 - 761. [Abstract] [Full Text] [PDF]